Last reviewed · How we verify

NCT05822401

Prevention, Management and Rehabilitation of Knee Osteoarthritis at the Workplace

Status unknown NA Last updated 20 April 2023
What this trial tests

NA trial testing Blood flow restriction (BFR) in Knee Pain Chronic in 80 participants. Status unknown.

Timeline
11 April 2023
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorNational Research Centre for the Working Environment, Denmark
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date11 April 2023
Primary completion31 December 2023
Estimated completion31 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

National Research Centre for the Working Environment, Denmark

Who can join

Adults 18 to 67, any sex, with Knee Pain Chronic or Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this intervention study is to assess the effect of blood flow restricted (BFR) exercise integrated into the daily work tasks among hospital workers with or at increased risk of chronic knee pain. The main questions are: Can BFR exercise integrated into the daily work tasks reduce knee pain (primary outcome) and improve function and work ability among hospital workers with or at increased risk of chronic knee pain? Participants in the intervention group will for shorts bouts during their workdays integrate BFR into their daily work tasks involving walking, whereas the control group will continue as usual.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood flow restriction (BFR)

Trials testing the same drug.

Other recruiting trials for Knee Pain Chronic

Currently open trials in the same condition.

Other National Research Centre for the Working Environment, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05822401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing